Fiducial markers: can the urologist do better?

Radiotherapy to the bladder has a risk of toxicity to pelvic structures, which can be reduced by using fiducial markers for targeting. Injectable contrast offers an alternative marker to gold seeds, which may fall out or exacerbate scarring. Combining contrast agents with tissue glue can minimize dispersion through tissue, enhancing its utility. We evaluated combinations of contrast agents and tissue glue using porcine bladder, for feasibility and utility as fiducial markers to aid image-guided radiotherapy.

Different contrast agents (Lipiodol ultra or Urografin) were combined with different tissue glues (Histoacryl, Tisseal or Glubran2). The mixtures were endoscopically injected into porcine bladder submucosa to identify the area of interest with multiple fiducial markers. The porcine bladders were imaged within a phantom porcine pelvis using standard radiation therapy imaging modalities. The feasibility as an injectable fiducial marker and visibility of each fiducial marker on imaging were scored as binary outcomes by two proceduralists and two radiation therapists, respectively.

Lipiodol-glue combinations were successfully administered as multiple fiducials that were evident on CT and CBCT. Lipiodol with Histoacryl or Glubran2 was visible on kV imaging. The Lipiodol Glubran2 combination was deemed subjectively easiest to use at delivery, and a better fiducial on KV imaging.

This study demonstrates the feasibility of mixing contrast medium Lipiodol with Histoacryl or Glubran2 tissue glue, which, injected endoscopically, provides discrete and visible fiducial markers to aid image-guided radiotherapy. Although promising, further study is required to assess the durability of these markers through a course of radiotherapy.

World journal of urology. 2018 Oct 04 [Epub ahead of print]

Catriona Duncan, Daryl Lim Joon, Nathan Lawrentschuk, Trish Jenkins, Michal Schneider, Vincent Khoo, Michael Chao, Marita Lawlor, Rachel O'Meara, Colleen Berry, Angela Viotto, Kerryn Brown, Morikatsu Wada, Farshad Foroudi, Shomik Sengupta

Department of Surgery, Austin Health, University of Melbourne, Melbourne, VIC, Australia., Department of Radiation Oncology, Olivia Newtown-John Cancer Centre, Austin Health, Melbourne, VIC, Australia., Royal Marsden NHS Foundation Trust, London, UK., Department of Surgery, Austin Health, University of Melbourne, Melbourne, VIC, Australia. .


Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.